The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementation of an oral chemotherapy adherence tool at an NCCN comprehensive cancer center.
 
Peter D. Whooley
No Relationships to Disclose
 
Fumei Cerecino
No Relationships to Disclose
 
Joy Kaye Weaver
No Relationships to Disclose
 
Maria Market
No Relationships to Disclose
 
Marie Riehl
No Relationships to Disclose
 
Lauren Ellis
No Relationships to Disclose
 
Andrew Beothy
No Relationships to Disclose
 
Jeff Karcsh
No Relationships to Disclose
 
Jeffrey Jean-Paul
No Relationships to Disclose
 
Anna Rodriguez
No Relationships to Disclose
 
Aruna Padmanabhan
No Relationships to Disclose
 
Martin Joseph Edelman
Stock and Other Ownership Interests - Biomarker Strategies
Consulting or Advisory Role - Flame Biosciences; Kanaph Therapeutics; Precision Oncology; Sanofi/Regeneron; WindMIL
Research Funding - Apexigen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Nektar (Inst); United Therapeutics (Inst); Windmil (Inst)
Patents, Royalties, Other Intellectual Property - Patent application for radiopharmaceutical to treat small cell lung cancer. (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - AstraZeneca/MedImmune; Boehringer Ingelheim; Seagen; Takeda
 
James Helstrom
No Relationships to Disclose
 
Daniel M. Geynisman
Consulting or Advisory Role - 2nd.MD; AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Harpoon therapeutics (Inst); Merck (Inst)